American Gene Technologies International Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:American Gene Technologies International Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10630
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
American Gene Technologies International Inc (AGT) is a drug development company that tests and commercializes gene-based drugs. The company develops therapies for the treatment of cancer, neurological disorders, AIDS, infectious diseases, Parkinson’s diseases, diabetes, familial dysautonomia, hepatocellular carcinoma, phenylketonuria, autosomal disorders, and other chronic human diseases. It also provides rapid drug development programs, genetic technologies and gamma delta T cell therapy, among others. AGT develops various products in the laboratory testing phase for oncology indications. The company partners with medical researchers, and pharmaceutical and biotech firms for its drug development activities. AGT is headquartered in Rockville, Maryland, the US.

American Gene Technologies International Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
American Gene Technologies International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
American Gene Technologies Raises USD1.2 Million in Venture Financing 10
American Gene Technologies Raises USD0.3 Million in Venture Financing 11
American Gene Technologies Raises USD1.3 Million in Venture Financing 12
Partnerships 13
GeoVax Labs Enters into Partnership with American Gene Technologies 13
American Gene Technologies Partners with University of Pittsburgh 14
American Gene Technologies International Inc – Key Competitors 15
American Gene Technologies International Inc – Key Employees 16
American Gene Technologies International Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Sep 11, 2017: American Gene Technologies Appoints Julia R. Brown to its Board of Directors 18
Apr 12, 2017: American Gene Technologies Announces C. Neil Lyons as Chief Financial Officer 19
Product News 20
10/12/2017: American Gene Technologies Inc. (AGT) Demonstrates Rationale of its Genetic Approach toward developing a Functional Cure for HIV Infection 20
Clinical Trials 21
Jan 25, 2018: American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Key Facts 2
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
American Gene Technologies International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
American Gene Technologies International Inc, Deals By Therapy Area, 2012 to YTD 2018 8
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
American Gene Technologies Raises USD1.2 Million in Venture Financing 10
American Gene Technologies Raises USD0.3 Million in Venture Financing 11
American Gene Technologies Raises USD1.3 Million in Venture Financing 12
GeoVax Labs Enters into Partnership with American Gene Technologies 13
American Gene Technologies Partners with University of Pittsburgh 14
American Gene Technologies International Inc, Key Competitors 15
American Gene Technologies International Inc, Key Employees 16

List of Figures
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[American Gene Technologies International Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Croatia Airlines dd:戦略・SWOT・企業財務分析
    Croatia Airlines dd - Strategy, SWOT and Corporate Finance Report Summary Croatia Airlines dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Public Service Enterprise Group Inc:発電所・企業SWOT分析
    Public Service Enterprise Group Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • The Boston Beer Company, Inc. (SAM):企業の財務・戦略的SWOT分析
    The Boston Beer Company, Inc. (SAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Blueknight Energy Partners LP:企業のM&A・事業提携・投資動向
    Blueknight Energy Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Blueknight Energy Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Reckitt Benckiser Group Plc (RB.):製薬・医療:M&Aディール及び事業提携情報
    Summary Reckitt Benckiser Group Plc (RB) is a consumer health and hygiene company that manufactures and markets household, toiletry and health care products. These consist of air fresheners, laundry products, dishwashing detergents, disinfectant sprays, water softeners, household cleaners, and perso …
  • Ignyta Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc, a subsidiary of F. Hoffmann-La Roche Ltd, is a cancer care service provider. The company discovers, develops and commercializes new drugs targeting activated genes in cancer cells. It develops products using integrated therapeutic technology (Rx/Dx). …
  • Whirlpool Corporation (WHR):企業の財務・戦略的SWOT分析
    Whirlpool Corporation (WHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ISA Pharmaceuticals BV:製薬・医療:M&Aディール及び事業提携情報
    Summary ISA Pharmaceuticals BV (ISA Pharmaceuticals) is a developer of synthetic therapeutic vaccines for the treatment of cancer and persistent viral infections. The company’s pipeline products include ISA101, an immunotherapeutic vaccine for cervical cancer; MyISA, a personalized immunotherapy bas …
  • The PNC Financial Services Group Inc:企業のM&A・事業提携・投資動向
    The PNC Financial Services Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The PNC Financial Services Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析
    R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Chesapeake Lodging Trust:企業のM&A・事業提携・投資動向
    Chesapeake Lodging Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chesapeake Lodging Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Dentsu Inc. (4324):企業の財務・戦略的SWOT分析
    Dentsu Inc. (4324) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Acea SpA (ACE):企業の財務・戦略的SWOT分析
    Acea SpA (ACE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Maxar Technologies Ltd (MAXR):企業の財務・戦略的SWOT分析
    Maxar Technologies Ltd (MAXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cost Plus Inc:企業の戦略的SWOT分析
    Cost Plus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • Ak Bars Bank
    Ak Bars Bank - Strategy, SWOT and Corporate Finance Report Summary Ak Bars Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • AltheaDx Inc-医療機器分野:企業M&A・提携分析
    Summary AltheaDx Inc (AltheaDx) is a biotechnology company that offers molecular diagnostic services. The company provides tests such as cardiovascular tests, pain tests, thrombophilia tests and psychiatric tests. It provides diagnostic development, clinical trial and discovery services. AltheaDx’ s …
  • New Balance Athletic Shoe Inc:企業の戦略的SWOT分析
    New Balance Athletic Shoe Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Trevena Inc (TRVN):企業の財務・戦略的SWOT分析
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆